These high-quality growth stocks could make you rich

Two high performers worth buying and holding for the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At a time when most markets are sitting at new highs, it’s more important than ever for growth investors to check they are buying companies fully capable of justifying their high valuations.  

With this in mind, here are two stocks that I believe are worth shelling out for.

Strong sales growth

Today’s set of interim numbers from FTSE 250 engineer Spirax-Sarco (LSE: SPX) goes some way to explaining just why its share price has climbed 28% in the last year. 

Over the first half of 2017, revenue at the £4.1bn cap climbed 25% (or 13% when currency fluctuations are taken into account) to £429m. According to the company, 5% of the sales growth was organic, with both its Steam Specialities business and the Spirax-owned pump manufacturer Watson-Marlow performing well. Importantly, this rate of growth was ahead of that achieved by global industrial production in general. Adjusted operating profit rose to £101m — a 31% increase (or 13% in constant currency). 

Rising over 2% in early trading, shares in Spirax currently change hands for 27 times forecast earnings. That might seem seriously expensive, but I think this valuation can be justified by the company’s market leading positions, geographically diversified operations and the consistently high returns on capital achieved over the years. Spirax’s balance sheet is rock solid and boasts a serious amount of cash. 

Furthermore, the recent acquisitions of Gestra (a global leader in valve and control systems for heat and fluid control) and Chromolax (which supplies electric heat and control products) will be earnings accretive in 2017, suggesting that full-year figures are likely to be even more positive than those announced this morning. 

In demand

Shares in global professional services provider and new FTSE 250 entrant FDM Holdings (LSE: FDM) have also been in fine form, rising 23% over the last month alone following June’s cracking set of interim figures.

In the first half of 2017, revenue climbed 35% to just over £117m with pre-tax profit hitting £20.6m — up 33% on the same period in 2016. Cash flow generated from operations rose 27% to £20m. 

The company’s IT and business consultants (or Mounties) have been in huge demand of late thanks to general concerns over cyber security and new EU data protection rules that come into force next May. Any businesses found to not be complying with these regulations faces being hit with severe financial penalties.

FDM’s presence across the world continues to grow, with “excellent performances” being witnessed in its North American and Asian Pacific markets (revenues rising 56% and 137% respectively). Revenue from Europe, the Middle East and Africa also climbed 12% from the previous period. Collectively, FDM’s overseas revenue now accounts for half of all that generated by the company’s IT consultants, suggesting that its shares should be fairly immune to any Brexit-induced volatility as the March 2019 deadline draws closer. The business welcomed 35 new clients over the interim period and continues to diversify across sectors, with 71% coming from outside financial services.

Like Spirax, buying a slice of FDM doesn’t come cheap. At 33 times earnings, the latter will need to continue performing seriously well to justify its steep valuation. With its board now anticipating that full-year figures will be “comfortably ahead of its previous expectations,” and there doesn’t seem much doubt about this. The recent 29% hike to the interim dividend is another sign of just how confident management appears to be on the company’s future prospects.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »